Clinical Trials Arena gives you the lung cancer highlights thus far from ASCO 2026. Credit: Keronn art / Shutterstock.com.
As professionals from across the oncology landscape gather at the 2026 American Society of Clinical Oncology (ASCO) congress in Chicago, many are looking to key readouts in lung cancer, the leading cause of cancer cases and deaths worldwide, according to the World Health Organization (WHO).
With several targeted therapies in the pipeline for subtypes under the wider lung cancer umbrella, there has already been a huge influx of fascinating readouts from the event. Pharmaceutical Technology gives you the highlights, with readouts from key players like Johnson & Johnson (J&J), Pfizer, Bristol Myers Squibb (BMS) and more. Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Find out more
